Literature DB >> 33033447

Preoperative lymphocyte-to-monocyte ratio versus platelet-to-lymphocyte ratio as a prognostic predictor for non-small cell lung cancer patients.

Haixi Yan1, Linling Cai1, Shuaishuai Chen1, Jun Li1.   

Abstract

BACKGROUND: We investigated the prognostic value of the preoperative lymphocyte-to-mononuclear ratio (LMR) and platelet-to-lymphocyte ratio (PLR) in a large cohort of patients with non-small cell lung cancer (NSCLC).
METHODS: Clinical-pathological data from 507 NSCLC patients at Taizhou Hospital of Zhejiang Province between 2010 and 2016 were retrospectively evaluated. X-tile software was used to assess the optimal cutoff levels for LMR and PLR. Univariate and multivariate Cox regression models were used to assess the prognostic factors.
RESULTS: The median follow-up duration after surgical resection was 34.5 months. Patients were stratified into 2 groups by LMR (2.6 and > 2.6) and PLR (179.6 and > 179.6). Our results revealed that lower LMR (HR = 3.163 (1.821-5.493), P = 0.000), age (HR = 2.252 (1.412-3.592), P = 0.001), T stage (HR = 3.749 (2.275-6.179), P = 0.000), N stage (HR = 3.106 (1.967-4.902), P = 0.000), and cut edge (HR = 3.830 (1.077-13.618), P = 0.038) were considered to be independent indicators for overall survival (OS) of NSCLC patients. For disease-free survival (DFS), age, sex, T stage, N stage, LMR and cut edge were verified to be independent prognostic factors in patients with NSCLC.
CONCLUSIONS: In the study cohort, reduced LMR was a robust independent predictor for both OS and DFS in patients with NSCLC who underwent surgical resection. 2020 Haixi Yan, Linling Cai, Shuaishuai Chen, Jun Li, published by CEON/CEES.

Entities:  

Keywords:  lymphocyte/monocyte; non-small cell lung cancer; platelet count/lymphocyte; prognosis overall survival - disease-free survival

Year:  2020        PMID: 33033447      PMCID: PMC7526025          DOI: 10.2478/jomb-2019-0031

Source DB:  PubMed          Journal:  J Med Biochem        ISSN: 1452-8266            Impact factor:   3.402


  19 in total

1.  Cancer statistics, 2015.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-01-05       Impact factor: 508.702

2.  X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization.

Authors:  Robert L Camp; Marisa Dolled-Filhart; David L Rimm
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

3.  The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis.

Authors:  X-M Ma; X Sun; G-W Yang; M-W Yu; G-L Zhang; J Yu; Y Zhang; X-M Wang
Journal:  Climacteric       Date:  2017-06-01       Impact factor: 3.005

4.  Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.

Authors:  Thomas K Hoffmann; Grzegorz Dworacki; Takashi Tsukihiro; Norbert Meidenbauer; William Gooding; Jonas T Johnson; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2002-08       Impact factor: 12.531

Review 5.  Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.

Authors:  Lin-Hua Zhou; Xiao-Feng Luo
Journal:  Clin Chim Acta       Date:  2017-09-10       Impact factor: 3.786

Review 6.  Regulation of Transdifferentiation and Retrodifferentiation by Inflammatory Cytokines in Hepatocellular Carcinoma.

Authors:  Florian Cabillic; Anne Corlu
Journal:  Gastroenterology       Date:  2016-07-19       Impact factor: 22.682

Review 7.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer.

Authors:  Graeme J K Guthrie; Kellie A Charles; Campbell S D Roxburgh; Paul G Horgan; Donald C McMillan; Stephen J Clarke
Journal:  Crit Rev Oncol Hematol       Date:  2013-04-17       Impact factor: 6.312

8.  Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  John A Howington; Matthew G Blum; Andrew C Chang; Alex A Balekian; Sudish C Murthy
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

9.  Soluble sPD-L1 and Serum Amyloid A1 as Potential Biomarkers for Lung Cancer.

Authors:  Dragana Jovanović; Marina Roksandić-Milenković; Jelena Kotur-Stevuljević; Vesna Ćeriman; Ivana Vukanić; Natalija Samardžić; Spasoje Popević; Branislav Ilić; Milija Gajić; Marioara Simon; Ioan Simon; Vesna Spasojević-Kalimanovska; Milica Belić; Damjan Mirkov; Zorica Šumarac; Vladislav Milenković
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

10.  Prognostic significance of combined fibrinogen concentration and neutrophil-to-lymphocyte ratio in patients with resectable non-small cell lung cancer.

Authors:  Wuhao Huang; Shengguang Wang; Hua Zhang; Bin Zhang; Changli Wang
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

View more
  1 in total

1.  Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.

Authors:  Dong Guo; Jiafeng Liu; Yanping Li; Chao Li; Quan Liu; Shengjun Ji; Shuchai Zhu
Journal:  J Inflamm Res       Date:  2021-11-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.